TI
LRMR icon

Trexquant Investment’s Larimar Therapeutics LRMR Stock Holding History

Trexquant Investment’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-123,066
Closed -$476K – 1735
2024
Q4 		$476K Sell
123,066
-28,041
-19% -$185K 0.01% 1294
2024
Q3 		$990K Sell
151,107
-35,067
-19% -$282K 0.01% 1056
2024
Q2 		$1.35M Buy
186,174
+139,980
+303% +$1.07M 0.02% 895
2024
Q1 		$351K Buy
+46,194
New +$360K 0.01% 1249
2023
Q2 		– Sell
-34,603
Closed -$157K – 1637
2023
Q1 		$157K Buy
+34,603
New +$181K ﹤0.01% 1354
2019
Q1 		– Sell
-2,408
Closed -$143K – 1161
2018
Q4 		$143K Buy
+2,408
New +$238K 0.01% 961
2018
Q3 		– Sell
-953
Closed -$117K – 1088
2018
Q2 		$117K Buy
+953
New +$81K 0.01% 827

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return